Experiences of Attending Group Education to Support Insulin Initiation in Type 2 Diabetes: A Qualitative Study by Upsher, Rebecca et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1007/s13300-019-00727-7
Document Version
Publisher's PDF, also known as Version of record
Link to publication record in King's Research Portal
Citation for published version (APA):
Upsher, R., Allen-Taylor, M., Reece, I., Chamley, M., Ismail, K., Forbes, A., & Winkley, K. (2019). Experiences of
Attending Group Education to Support Insulin Initiation in Type 2 Diabetes: A Qualitative Study. Diabetes
Therapy, 11(1), 119-132. https://doi.org/10.1007/s13300-019-00727-7
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 10. Jul. 2020
ORIGINAL RESEARCH
Experiences of Attending Group Education to Support
Insulin Initiation in Type 2 Diabetes: A Qualitative
Study
Rebecca Upsher . Maya Allen-Taylor . Ilse Reece . Mark Chamley .
Khalida Ismail . Angus Forbes . Kirsty Winkley
Received: September 5, 2019
 The Author(s) 2019
ABSTRACT
Introduction: Type 2 diabetes is a progressive
condition and many people require insulin
therapy 5–10 years post diagnosis. Considering
the global increase in type 2 diabetes, group
education programmes to initiate insulin are
beneficial as they are cost-effective and provide
peer support. However, group education to ini-
tiate insulin has not been widely evaluated and
there is a need to elicit the views and experience
of people with type 2 diabetes who start insulin
in groups. The aim of this study was to explore
the perspectives of people with type 2 diabetes
who receive nurse-led group-based insulin
education.
Methods: Qualitative, semi-structured inter-
views of people with type 2 diabetes in south
London, UK, who had attended group educa-
tion sessions to start insulin. Inductive thematic
analysis identified themes within the data.
Results: Fifteen people with type 2 diabetes
were interviewed. Three main themes were
identified: creating a supportive environment;
facilitator skills; and effectiveness of group.
Factors which created a supportive environ-
ment included peer support, providing reassur-
ance and printed materials. Facilitator skills
associated with positive experiences included
addressing negative insulin beliefs and manag-
ing group dynamics. The effectiveness of the
group was determined by ongoing self-man-
agement success, need for more peer support,
and insulin concerns post insulin education
group.
Conclusion: Positive experiences of insulin
group education for people with type 2 diabetes
were associated with sharing experiences with
other people starting insulin, reassurance from
healthcare professionals, appropriate supportive
materials, and skill of the facilitator to address
insulin concerns and manage group dynamics.
People with type 2 diabetes may benefit more
from education if healthcare professionals are
skilled in psychological techniques to facilitate
group education aimed at addressing concerns
around insulin therapy. Further research needs
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to assess the effectiveness of structured insulin
group education for people with type 2 diabetes.
Keywords: Diabetes nurse; Education; Health
care delivery; Insulin therapy; Psychological
aspects; Self-management; Type 2 diabetes
Key Summary Points
Why carry out this study?
There is global increase in the number of
people with type 2 diabetes and as a result
of its progressive nature more people will
require insulin injection therapy.
Group education is a cost-effective
approach to starting insulin requiring
fewer diabetes nurse specialist educators.
This study aims to explore the
perspectives of people with type 2 diabetes
of group-based insulin education.
What was learned from the study?
This qualitative research demonstrates
that peer support and appropriate
resources aid group insulin initiation
education.
However, concerns following insulin
education suggest that improvement is
required and some nurses require training
to address anxiety around insulin therapy.
Further work is needed to make insulin
initiation groups equitable to all.
INTRODUCTION
There are an estimated 422 million people with
type 2 diabetes living with diabetes worldwide
[1], costing world healthcare services over 827
billion US dollars [2, 3]. Type 2 diabetes is a
progressive condition if not managed inten-
sively with weight-loss strategies from diagnosis
[4], and which are not achievable for many
people. And even with optimal glycaemic
control and appropriate medication regimes,
beta cell function deteriorates over time [5].
Therefore, a large proportion of people with
type 2 diabetes require insulin injections
around 5–10 years from diagnosis, a treatment
which is associated with improved glycaemic
control [6] and reduced risk of diabetes com-
plications [7]. With the growing population of
type 2 diabetes, there has been a shift from
initiating and managing insulin in secondary
care to primary care [8]. However, a recent UK
survey found a shortage of diabetes specialists
nurses/educators, fewer qualified nurses recrui-
ted into diabetes specialist roles, and an esti-
mated 57% of diabetes specialist nurses due to
retire within 10 years [9]. Additionally, primary
care nurses who are trained to support people
with insulin education are also a limited
resource. There is a similar picture in North
America [10]. Therefore, there are fewer diabetes
specialist nurses available with specialist skills
to initiate insulin. A solution, requiring fewer
specialists, is to provide insulin education in
groups. Diabetes group education is cost-effec-
tive compared with individual support [11].
In the south London borough of Lambeth
(UK) there is an existing ‘insulin start group’ for
people with type 2 diabetes newly prescribed
insulin therapy. The group comprises two ses-
sions (2 h each) 1 week apart to provide key
educational and safety information around ini-
tiating and self-managing with insulin. The
curriculum includes type 2 diabetes progres-
sion; safe insulin administration; insulin stor-
age; dose titration; hypoglycaemia; driving with
insulin; blood glucose readings review; sick day
rules; travelling with insulin; and interpreting
results of annual reviews. There are up to six
people per group and are facilitated by diabetes
specialist nurses/educators. Referral to these
insulin start groups is made by general practi-
tioners in primary care. There is evidence that
group education for people with type 2 diabetes
can improve diabetes self-management and
glycaemic control [12–16], and is viewed
favourably by healthcare professionals [17].
However, the evidence is for diabetes self-man-
agement education in general; less is known
about type 2 diabetes insulin education groups.
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People with type 2 diabetes have reported
many negative beliefs around insulin therapy
[14, 18, 19], termed psychological insulin resis-
tance [20–22], which include sense of personal
failure [23]; social stigma [24]; and fears of
injections [25], lifestyle change [26], side effects,
complications [25], and weight gain [27]. People
with type 2 diabetes are likely to discontinue
insulin if concerns are not addressed [28].
However, there is currently no national or
international guidance on how to address
insulin concerns for people with type 2 diabetes
[29] which could be incorporated into educa-
tion groups to provide optimal support.
In summary, insulin education groups are
useful to reduce cost burden for health services
and maximise the expertise of diabetes special-
ist nurses as the number of people with type 2
diabetes continues to rise. Therefore, it is
important to gauge the views of people with
type 2 diabetes who have attended insulin
education groups to identify views on the bar-
riers to insulin self-management, and sugges-
tions for additional support to maximise the
potential of aiding insulin self-management in
type 2 diabetes. The aim of this study was to
qualitatively evaluate the experiences of people
with type 2 diabetes who had attended an
insulin start group in south London.
METHODS
This study employed a qualitative design using
semi-structured one-to-one interviews of people
with type 2 diabetes from south London. This
qualitative research was reported according to
the ‘consolidated criteria for reporting qualita-
tive research checklist’. Ethical approval was
obtained by King’s College Hospital (ref. 17/LO/
0363). Participants were provided with infor-
mation sheets before commencing the study,
were given time to consider the information
and ask the researchersquestions. They were
informed of their right to withdraw at any time.
Participants signed a consent form. Personal
identifiers were removed and cannot be identi-
fied in this report. This study was performed in
accordance with the Helsinki Declaration of
1964 and its later amendments.
Recruitment and Sample
English-speaking adults (at least 18 years old)
with type 2 diabetes were invited to participate
in the study if they had attended an insulin start
group in south London and commenced insu-
lin. All participants received the same type of
education facilitated by diabetes specialist nur-
ses/educators at community venues in south
London after receiving their first insulin pre-
scription. People attending the insulin start
groups started on once daily basal insulin, with
a starting dose of 10 units which they were
taught how to titrate within the group. People
with type 2 diabetes were purposively sampled
by gender, age (B 45, 46–59, 60? years), and
ethnicity (white, black, South Asian/other).
Development of Interview Schedule
An initial interview topic guide was designed by
three researchers (RU, KW, MA) on the basis of
current literature (Table 1). The interview
schedule was assessed for face validity through
Table 1 Topic guide for interview schedule
Reasons for referral to diabetes specialist team
Need for insulin, barriers to uptake and adherence
Benefits of insulin
Disadvantages of insulin
Delay in insulin?
Concerns/worries before insulin initiation
Views on insulin self-management support
Views on group insulin education
Positive views on insulin self-management support
Less positive/helpful aspects of insulin self-
management support
Readiness to initiate insulin
Follow-up support
Recommendations for future insulin education
support
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discussion with healthcare professionals and
piloting the interview on two people with type
2 diabetes who had attended an insulin start
group; topics guides were then revised. For
subsequent interviews, each researcher listened
to audiotapes of interviews conducted by the
other two researchers for fidelity purposes,
allowing reflection and discussion of interview
technique, and to identify any interviewer bias
to be eliminated in subsequent interviews.
Topic guides were revised as required to account
for individual interviewing styles and for rigor-
ous data collection.
Data Collection
Interviews were conducted by one of the three
female researchers who had experience with
conducting qualitative research and were based
at King’s College London; two researchers were
also diabetes specialist nurses (MA, KW). Dia-
betes specialist nurses did not interview any
person with diabetes for whom they had per-
sonally educated. Eligible participants were
identified on Egton Medical Information Sys-
tems (medical record system) by diabetes spe-
cialist nurses on the research team who were
then contacted via telephone and, if willing,
arranged a date and time for the interview.
Interviewees were given the choice of interview
location to maximise recruitment: King’s Col-
lege London research facility or the partici-
pants’ local general practice surgery.
Participants were informed that the study
was funded by the National Institute for Health
Research and the specific purpose of the project
was to determine views on the barriers to insu-
lin self-management, views on diabetes educa-
tion courses, and suggestions for additional
support to aid insulin self-management in type
2 diabetes. Each participant was interviewed
once. To ascertain adequate sample size, after
every three interviews, the transcripts were
assessed (by RU and KW) for information power
based on study aim (views of insulin education
received); sample specificity (people who
attended an insulin start group and sample
based on age, gender and ethnicity); quality of
dialogue (assessed by knowledge base of
researchers as well as rapport between
researcher and participants); and analysis strat-
egy (outlined below) [30].
Data Analysis
Interviews were transcribed and anonymised
data from transcripts were managed in NVivo12
(qualitative computer software). Inductive the-
matic analysis identified themes within the data
via six stages [31]: (1) familiarisation of data by
reading of transcripts and listening to audio-
tapes, making notes of initial impressions; (2)
generation of initial codes (RU and MA;
reviewed by KW); (3) searching for themes by
collating codes that depict the data; (4)
reviewing themes and making sure the themes
apply accurately to all coded data; (5) defining
and naming each theme to describe which
aspects of the data the theme represents; (6)
producing a final report.
RESULTS
A total of 15 people with type 2 diabetes were
recruited. The mean age was 61.40 (SD = 10.58),
the majority were female (53.3%), 60 years or
over (53.3%), and Black African or Caribbean
ethnicity (60%) (Tables 2, 3). The mean diabetes
duration was 11.33 years (SD = 7.18). The mean
HbA1c level was 73.53 mmol/mol (SD = 21.49).
Diabetes treatment is reported in Table 2. The
most common insulin treatment was Humulin I
(73.3%), and most common oral antidiabetic
medication combination was metformin, gli-
clazide and sitagliptin (33.3%). Three people
were prescribed glucagon-like peptide 1 treat-
ment. No one dropped out of the study, one
person declined to participate (lack of time),
and there were three people who were eligible
but did not respond to the research team. The
mean duration of interviews was 28.10 min
(SD = 9.82).
The analysis generated three key themes: 1.
creating a supportive environment; 2. facilitator
skills; 3. effectiveness of group. There were fur-
ther subthemes within each theme (Fig. 1).
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Creating a Supportive Environment
An environment which best provided insulin
self-management support consisted of three
components including group members (peers),
group facilitators, and supportive resources
(printed materials).
Table 2 Overall demographics of interviewees with type 2
diabetes
Characteristics Number Percentage Mean (SD)
Age 61.40 (10.58)
B 45 2 13.3
46–59 5 33.3
60? 8 53.3
Ethnicity
Black African/
Caribbean
9 60.0
Caucasian 5 33.3
Asian/other 1 6.7
Gender
Female 8 53.3
Male 7 46.7
Diabetes duration 11.33 (7.18)
HbA1c 73.53 (21.49)
Insulin type
Humulin I 11 73.3
Novomix 30 2 13.3
Lantus 1 6.7
Abasaglar 1 6.7
Oral antidiabetic medications
Zero 2 13.3
Gliclazide only 2 13.3
Metformin only 2 13.3
Metformin and
gliclazide
2 13.3
Metformin,
gliclazide,
sitagliptin
5 33.3
Metformin,
gliclazide and
linagliptin
2 13.3
Glucagon-like peptide-1
Zero 12 80
Table 2 continued
Characteristics Number Percentage Mean (SD)
Dulaglutide 2 13.3
Liraglutide 1 6.7
Table 3 Demographics of each interviewee with type 2
diabetes
Participant
number
Age
group
Sex Ethnic group
1 46–59 Female Black African/Caribbean
2 60? Female Asian/other
3 60? Female White
4 60? Male White
5 46–59 Female Black African/Caribbean
6 60? Male Black African/Caribbean
7 B 45 Male Black African/Caribbean
8 46–59 Female White
9 60? Female White
10 60? Female White
11 60? Female Black African/Caribbean
12 46–59 Male Black African/Caribbean
13 60? Male Black African/Caribbean
14 46–59 Male Black African/Caribbean
15 B 45 Male Black African/Caribbean
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Peer Support
Many conveyed that being in a group was a
positive supportive experience, e.g. to hear dif-
ferent people’s perspective, to share one’s own
experience, and being with other people with
diabetes (quotations are followed by participant
number and gender in parentheses):
‘‘…you can come in and then share your
experience and also gain from other peo-
ple’s experience…’’ (13M).
‘‘You feel more comfortable, you are not
the only one [with diabetes]…I was happy
as well because I’m going to see other
people as well’’ (08F).
Another highlighted a sense of personal
failure in relation to having to take insulin for
their diabetes but feeling comforted by a range
of people in the group being in the same situ-
ation as themselves:
‘‘…so thinking, ‘‘What have I done
wrong?’’, but when you sit around, you see
young ones, old ones, and everybody’s
been on it [insulin], it’s kind of an inspi-
ration’’ (12M).
Providing Reassurance
Reassurance was provided by the insulin group
facilitator who would deliver important educa-
tional information such as frequency of
injections:
‘‘Well reassurance from them that it wasn’t
going to be a big task to take the injections
every night and it was only one’’ (04M).
The type of information was not the only
important factor in providing reassurance but
the way in which the information was com-
municated led to feelings of empowerment:
‘‘I was empowered, you know, the nurse
explained a lot of things to us’’ (01F).
Printed Materials
For some, printed materials which were given to
the group to take home, were an informative
resource to support the educational content and
reinforce knowledge learnt:
‘‘Yes, they are informative, you know, they
have a lot of information that you need to
know about diabetes and insulin, you
know’’ (06M).
Fig. 1 Summary of themes and subthemes
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‘‘The leaflets were just a form of reinforce-
ment, that’s what they were’’ (15M).
Others reported negatively on these resour-
ces which led to them being unread or thrown
away, one explanation was this was due to
being given too many leaflets:
‘‘if you had a lot of papers, you know, some
of it might go missing…but few I read
honestly’’ (01F).
‘‘I probably binned them, but they were,
they were useful at the time’’ (10F).
Other interviewees suggested that the prin-
ted materials were not suitable for all audiences
such as those where English is not their first
language:
‘‘lots of information papers but they are too
much to read, especially because English is
not my language that’s why maybe’’ (02F).
Facilitator Skills
It was important for facilitators to have the
appropriate skills to manage concerns around
insulin therapy within the groups. Managing
group dynamics could be positively or nega-
tively attributed to the skill of the facilitator.
Addressing Negative Insulin Beliefs
One approach group facilitators used to address
fear of injections was practical demonstrations
and practice of injecting which eliminated
concerns for some:
‘‘I had a go at doing the injection. And
then, you know, I thought oh my God, this
is fine’’ (01F).
However, facilitators did not address fears for
all, one interviewee described feelings of anxi-
ety which prevented retention of information:
‘‘…of course being human beings we
sometimes shut down from things that we
fear…. So we don’t necessarily take
onboard as much as we could do were we
not human beings that have fears and
anxieties and personalities…’’ (03F).
In addition, there was one account indicat-
ing that the diabetes specialist nurse facilitator
lacked skills to support fears around insulin:
‘‘there was one lady who was really fright-
ened…I noticed that the nurse wasn’t per-
suading her or doing any other thing
except just explaining what it [insulin]
was…’’ (13M).
Managing Group Dynamics
An interviewee described the importance of the
diabetes specialist nurse facilitator allowing
time for everyone’s questions and managing
different people within the group to check their
understanding:
‘‘Because they take a small number of
people and the nurses…gives yourself time
to talk to people individually and then,
you know, some people…take time to
digest information but then the nurse has
got time to listen to those people and then
explain further so that people understand
the session’’ (01F).
There were, however, reports of frustration
around listening to other group members’
experiences indicating that group dynamics
were not well managed in some cases:
‘‘…listening to other people’s experience,
plenty of time was given so people could
go on and on and on, that may be some-
thing to manage, yeah, because people can
go into their lifetime stories and many of
them moved away from the point being
discussed’’ (13M).
In related accounts, a preference for one-to-
one education was expressed so questions could
be answered unlike their experience within a
group:
‘‘You know, we’re in a group, you can’t
keep on asking questions when other peo-
ple have their hands up…if it’s like one-to-
one thing you’ve been apportioned a time,
like fifty minutes I’m going to be with you,
ask all the question…’’ (12M).
There was an indication that people in the
group were at different ‘levels’ including insulin
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experience (i.e. previously on injection therapy)
and age; these factors were not controlled
within the group setting:
‘‘I’m more experienced than they are….
I’ve been injecting myself [previously], so
it, it was a bit pedestrian for, really it was a
bit pedestrian…it wasn’t the same for me
as it was for these people trying to learn
how to inject themselves’’ (10F).
‘‘…the kind of only daunting thing for me
was that when you’re seeing a lot of people
much, much older around you [in the
group]…’’ (07M).
Effectiveness of Group
By gauging knowledge and beliefs of people
who had attended insulin group education,
inferences could be made about the effective-
ness of the group. Subthemes which were indi-
cators of effectiveness of the insulin group
include ongoing management success, need for
more peer support, and insulin concerns post
group.
Ongoing Self-Management Success
Success of insulin self-management post insulin
group was highlighted by improvement in
blood glucose levels:
‘‘…my sugar levels are down. I’m a happy
person’’ (01F).
However, not all diabetes self-management
feedback post insulin group was positive. For
example, groups did not appear to take into
consideration cultural differences in diet and
lifestyle, with one report of need for education
around Afro-Caribbean diets and diabetes:
‘‘…with the greatest respect there is the
marked difference between a Western diet
and Afro-Caribbean and even an Asian
diet, there’s a marked difference. So…with
the best of intentions making a suggestion
to somebody from another culture without
understanding their own diet, the advice
might sound alien…’’ (15M).
Other self-management techniques which
required more attention in insulin groups
included injection technique, and describing
the different types of insulin:
‘‘I find the actual injection thing, I find it
very hard to press it, because you’re hold-
ing your…you know, and then you have to
put it in, I find that very hard…’’ (09F).
‘‘I thought they should have explained to
us why some people, they call it active,
instant reacting insulin, why are some
people on that and some people on the
other one?’’ (12M).
There was also lack of knowledge around
knowing how to react to pseudohypoglycaemia.
This is an event of hypoglycaemia symptoms
that can occur when blood glucose levels are
greater than 3.9 mmol/L (70 mg/dL) (i.e. not
hypoglycaemic levels) resulting from previous
exposure to long-term hyperglycaemia:
‘‘I woke up this morning feeling a bit, I
don’t know, I haven’t felt like this for a
long time, I feel dizzy. In fact, I took my,
when I was not feeling well, I took my
blood to test it. It wasn’t even on hypo
level, so I don’t know why I was feeling like
that…’’ (11F).
Need for More Peer Support
Need for further peer support beyond the insu-
lin education groups was indicated by wanting
more social activities and meeting up with
group members living close by:
‘‘But then they can always encourage that
little group that’s local to each other. I
don’t know whether you realise it but like
there’s six of you in this room at the
moment that are all within a mile of each
other’’ (03F).
Also, some expressed a desire for follow-up
group or ‘booster’ sessions to refresh content
learnt in groups:
‘‘how to put that into refresh my mind for
that to come up, plus I used to forget
something, very soon I will forget every-
thing, yeah’’ (14M).
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However, others were content with the
original two sessions:
‘‘The two groups were just right’’ (13M).
Not only face-to-face support was mentioned
but one participant also shared their positive
experience of peer support via a web support
group to ask questions about diabetes and
insulin:
‘‘I’m able to contact other people and if I
have questions I’m able to post it and have
somebody who’s had that experience so it’s
a continuous thing’’ (13M).
Insulin Concerns Post Group
There were some positive accounts of insulin
therapy such as confidence in insulin efficacy
and taking insulin, and improved well-being:
‘‘I felt confident to start it and since then
I’ve been doing it’’ (06M).
‘‘It’s made me, you know, feel myself
again’’ (01F).
However, interviewees did recount a range
concerns which remained post insulin group
such as injecting for life, hypoglycaemia, where
to inject, and weight gain. This suggests that the
insulin groups were not effective in eliminating
all concerns around insulin therapy:
‘‘Just think about injecting myself for the
rest of my life, I think that’s one of the
biggest disadvantage for me you know’’
(07M).
‘‘The hypo quite a lot…I feel quite dizzy’’
(11F).
‘‘I’m having a problem with the injection,
you know, that is locating areas in my
tummy where to inject’’ (06M).
‘‘I noticed that I put on weight with insu-
lin’’ (12M).
Another concern from one interviewee was
travelling with insulin, which now prevented
him from seeing friends as he did not want to
take insulin with him:
‘‘Even I go and stay with a friend of mine
down in Crawley and since I’ve been on
insulin I haven’t been down to see him
because I don’t want to be taking medica-
tion down with me’’ (04M).
DISCUSSION
The aim of this qualitative interview study was
to identify perceptions of group insulin educa-
tion for people with type 2 diabetes. Interviews
of people with type 2 diabetes who had atten-
ded group insulin education in south London
revealed three main themes: creating a sup-
portive environment, facilitator skills, and
effectiveness of group.
Creating a Supportive Environment
Social support including peer support is impor-
tant for improving outcomes in type 2 diabetes
[32, 33]. We found that peer support in insulin
group education led to positive experiences as
well as reducing personal failure related to
starting insulin by being around other people in
the same situation.
Previous research indicates that acceptance
of insulin therapy is associated with healthcare
professional support [34]. Diabetes nurses/edu-
cators providing reassurance was found to be
beneficial in our analysis. Reassurance was also
achieved by providing important educational
information as well as the way in which infor-
mation was communicated to empower the
group.
Printed materials were given to group mem-
bers to support learning. These generated mixed
reviews, some finding them informative and
others criticising the volume of paperwork.
These materials were also difficult for those
whose first language was not English. Further
consideration is required to make resources
equitable for all.
Facilitator Skills
Previous research has indicated that starting
insulin can decrease negative insulin beliefs
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such as fears of hypoglycaemia [35]. However, it
is unknown whether this is related to receiving
certain types of insulin education or the skill of
the diabetes nurse/educator. Our study found
that fears of injecting were addressed in group
insulin education through practical demon-
strations and practising injecting in the group.
This is supported by the wider literature where
there is evidence that receipt of practical advice,
such as insulin injection demonstrations, helps
people with type 2 diabetes avoid delays in
initiating insulin [36].
However, we also found that not all inter-
viewees were satisfied and communicated that
the facilitator lacked skills to support or address
their fears and anxiety around insulin therapy.
In addition, in some circumstances facilitators
did not manage group dynamics well and some
participants expressed concerns as some of the
diabetes nurses did not answer everyone’s
questions, and were not effective at managing
people at different life stages e.g. level of insulin
knowledge and experience or age group. Whilst
some diabetes specialist nurses delivering insu-
lin start groups in south London might have
had some group education training for other
diabetes education groups, e.g. DESMOND (Di-
abetes Education and Self-Management for
Ongoing and Newly Diagnosed), they are often
expected to run insulin start groups without
formal training. There is no current accredited
insulin start groups training in the UK which
may account for inconsistences in facilitator
skill. Meta-analyses have demonstrated that
psychological interventions using cognitive
behavioural therapy and counselling can help
support people with type 2 diabetes to self-
manage and improve glycaemic control
[37, 38]. Whilst, some of the included studies
were delivered to groups of people, they were
not specifically related to insulin initiation.
However, facilitators trained in these psycho-
logical skills might be better equipped to
address insulin concerns in a group setting.
Effectiveness of Group
Previous research related to group type 2 dia-
betes education has demonstrated
improvements in glycaemic control [12–16].
Our findings provide further support for group
type 2 diabetes education with interviewees
providing accounts of improved blood glucose
readings post insulin education group. There
were also negative reports including lack of
consideration for cultural differences in relation
to dietary content. It is important to consider
these differences as culturally appropriate edu-
cation for people with type 2 diabetes is asso-
ciated with improvement in glycaemic control
and knowledge compared with untailored
group education [39].
The insulin start group education delivered
to participants in this study is not equivalent to
structured education (with a manualised evi-
dence-based curriculum); hence this may
account for descriptions of missing elements of
insulin education such as injection technique,
types of insulin and hypoglycaemia awareness
in some groups. An insulin education group
which is defined as structured education
according to UK guidelines [40, 41] could
eliminate inconsistency in curriculum between
groups.
The need for more peer support which was
indicated by desire for social activities, group
booster sessions and web support might suggest
that the insulin group was not entirely suc-
cessful in terms of providing support necessary
to independently self-manage. Nevertheless,
additional peer support may help support self-
management in the longer term where group
diabetes education has previously found to be
unsuccessful [42, 43].
Strengths and Limitations of Current
Research
We aimed to adopt a reflexive research design
by including a multidisciplinary authorship
team to allow for a broad understanding of the
topic from design, analysis and interpretation of
findings. A strength of our findings is the
transferability of the results. Ultimately deter-
mining the transferability of the results is down
to the reader who decides whether they can be
applied to another sociocultural setting [44] and
this can be aided by applying study results to
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existing theoretical health models. Our study
can be applied to the COM-B (‘capability’, ‘op-
portunity’, ‘motivation’ and ‘behaviour’) health
behaviour model [45]. For example, our theme
‘Ongoing self-management success’ (theme 3.a)
relates to the capability of self-managing with
insulin in terms of knowledge and skill. The
theme ‘Insulin concerns post group’ (theme 3.c)
relates to the motivation to use insulin therapy
(e.g. confidence to inject and plans to do so).
Finally, our theme ‘Need for more peer support’
(theme 3.b) relates to the opportunity to self-
manage with insulin in terms of physical
opportunity (e.g. travelling with insulin) or
having social support. Furthermore, this sup-
ports using the COM-B model to redesign future
insulin education interventions.
Although the sample was limited to south
London, this area is diverse in terms of ethnicity
and socio-economic status and our sampling
strategy took this into consideration. Therefore,
what is learnt from this population is likely to
be transferable to other areas of the UK and
western Europe. We considered recruitment of
majority Black African or Caribbean ethnic
group an advantage due to the large population
of people from non-white European ethnicity in
south London. Even though the minority of our
sample was of South Asian ethnicity, difficulty
in recruiting this demographic was anticipated
owing to previous research of people with type
2 diabetes from south London [17, 46]. This
group has a low prevalence compared with
other ethnic groups; therefore, there was a
smaller pool of people from this ethnic group to
sample who had attended an insulin start
group. Although we felt that audiotapes were
accurately transcribed and there was consis-
tency between the data presented and findings,
a potential limitation is that we did not return
transcripts to participants for comment or cor-
rection, and participants did not provide feed-
back on findings. In future research these
additional measures could be taken to deter-
mine whether participants provide further
insight post interview.
CONCLUSIONS
This study highlights the importance of peer
support and facilitator skill in creating a posi-
tive supportive environment in group insulin
education. However, diabetes specialist nurses
delivering group insulin education may need to
develop psychological skills to enhance patient
communication, better manage group dynam-
ics, and to address concerns around insulin
therapy. In addition, insulin group content and
supporting printed materials need to be further
developed to be equitable to all regarding lan-
guage and cultural differences. Follow-up peer
support could be useful in optimising ongoing
insulin self-management. This study provides a
foundation for developing structured insulin
education groups, and subsequently informing
standardised treatment guidance around insu-
lin education.
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